Relative effects of pregnancy and corticosterone administration on skeletal muscle metabolism in the rat.
The effects of pregnancy and corticosterone treatment on skeletal muscle metabolism were compared using a noncyclically perfused rat hindlimb preparation. Animal groups studied included 3-week-pregnant animals, rats injected with corticosterone (7.5 mg/100 g BW . day) for 3 days, and age-matched control rats. All were fasted 24 h before perfusion. In baseline perfusions devoid of insulin, no differences were observed among the groups with respect to muscle glucose uptake and the release of lactate, pyruvate, and glycerol. Baseline alanine and phenylalanine release were significantly increased in corticosterone-treated rats compared to values observed in control and pregnant animals. In perfusions with 100 or 500 microU/ml insulin, glucose uptake was increased 5-fold above baseline uptake in the control group. At 100 microU/ml insulin concentrations, glucose uptake in pregnant and corticosterone-treated rats achieved only 50% of the increase seen in control experiments. With 500 microU/ml insulin, glucose uptake was decreased 20% in pregnant animals and 40% in rats receiving corticosterone relative to control values. Alanine release was significantly reduced below baseline after the administration of 500 microU/ml insulin in control rats. In these rats, phenylalanine release, an index of net protein degradation, also was reduced with both 100 and 500 microU/ml insulin. Similar insulin concentrations did not suppress the efflux of either amino acid below baseline in pregnant or corticosterone-treated groups. Corticosterone administration to nonpregnant rats appears to duplicate changes in skeletal muscle metabolism that occur during late rat pregnancy. Insulin resistance in both states is manifested by a decrease in insulin-stimulated glucose uptake and an inability of insulin to suppress net muscle proteolysis. Since plasma free glucocorticoid concentrations are increased in late human as well as rat gestation, these steroids may have an important role in the development of insulin resistance at skeletal muscle sites in this state.
D000596:Amino Acids / Q000378:metabolism; D000818:Animals; D003345:Corticosterone / Q000494:pharmacology*; D005260:Female; D005947:Glucose / Q000378:metabolism; D005990:Glycerol / Q000378:metabolism; D007328:Insulin / Q000494:pharmacology; D007773:Lactates / Q000378:metabolism; D019344:Lactic Acid; D009132:Muscles / Q000187:drug effects / Q000378:metabolism*; D010477:Perfusion; D011247:Pregnancy; D011270:Pregnancy, Animal; D051381:Rats; D011919:Rats, Inbred Strains
D000596:Amino Acids; D007328:Insulin; D007773:Lactates; D019344:Lactic Acid; D005947:Glucose; D005990:Glycerol; D003345:Corticosterone